A QSP model of prostate cancer immunotherapy to identify effective combination therapies

Immunotherapy, by enhancing the endogenous anti-tumor immune responses, is showing promising results for the treatment of numerous cancers refractory to conventional therapies. However, its effectiveness for advanced castration-resistant prostate cancer remains unsatisfactory and new therapeutic str...

Descripción completa

Detalles Bibliográficos
Autores principales: Coletti, Roberta, Leonardelli, Lorena, Parolo, Silvia, Marchetti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270132/
https://www.ncbi.nlm.nih.gov/pubmed/32493951
http://dx.doi.org/10.1038/s41598-020-65590-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270132/
https://www.ncbi.nlm.nih.gov/pubmed/32493951
http://dx.doi.org/10.1038/s41598-020-65590-0

Ejemplares similares